NCT07435467Recruiting
Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER)
Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER): a Multicenter, Observational, 3-arms, Prospective Study
Source: ClinicalTrials.gov · Last updated 27 Feb 2026
Brief summary (registry, in English)
The BAD-GER study is a multicenter, prospective, three-arm observational study serving to validate a prognostic biomarker algorithm for mortality and hospital readmission; this algorithm will be developed through the retrospective analysis of Alzheimer's Disease and neurodegeneration biomarkers in an already available discovery cohort of 700 previously hospitalized geriatric patients.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 19 Feb 2026
- Start date
- 9 Apr 2025
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- Istituto Nazionale di Ricovero e Cura per Anziani
- Diseases
- Alzheimer disease
- NCT number
- NCT07435467
What you commit to
- Study type: Observational
- Planned participants: 400
- From 9 Apr 2025 to the primary completion date, 30 Jun 2026
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- no informed consent
- GROUP 2: Patients hospitalized for non-neurological diseases with dementia
- Inpatients with one of the following diagnoses: ischemic or hemorrhagic stroke, delirium, status epilepticus, encephalitis/meningitis
- no informed consent
- GROUP 3: Patients hospitalized for non-neurological diseases without dementia
- inpatients with one of the following diagnoses: ischemic or hemorrhagic stroke, delirium, status epilepticus, encephalitis/meningitis
- diagnosis of dementia
Other
- no informed consent
Who the study is looking for
- Inpatients with one of the following diagnoses: ischemic or hemorrhagic stroke, delirium, status epilepticus, encephalitis/meningitis
- inpatients with diagnosis of major neurocognitive disorder according to DSM-5 criteria (2013)
- inpatients with non-neurological diseases
Criteria the registry did not label
- GROUP 1: Patients hospitalized for acute neurological disorders
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS INRCA Hospital Coordinator of this site? Confirm its status | Ancona | Italy | Recruiting |
| IRCCS INRCA Hospital Coordinator of this site? Confirm its status | Fermo | Italy | Recruiting |
| Policlinico Universitario Coordinator of this site? Confirm its status | Messina | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.